SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-055540
Filing Date
2017-11-01
Accepted
2017-11-01 17:02:08
Documents
54
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv477382_10q.htm 10-Q 439213
2 EXHIBIT 31.1 tv477382_ex31-1.htm EX-31.1 12441
3 EXHIBIT 31.2 tv477382_ex31-2.htm EX-31.2 12402
4 EXHIBIT 32.1 tv477382_ex32-1.htm EX-32.1 4812
5 EXHIBIT 32.2 tv477382_ex32-2.htm EX-32.2 4897
6 GRAPHIC image_001.jpg GRAPHIC 27133
  Complete submission text file 0001144204-17-055540.txt   3997607

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT syn-20170930.xml EX-101.INS 1041881
8 XBRL TAXONOMY EXTENSION SCHEMA syn-20170930.xsd EX-101.SCH 34351
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20170930_cal.xml EX-101.CAL 32493
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20170930_def.xml EX-101.DEF 208422
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20170930_lab.xml EX-101.LAB 264392
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20170930_pre.xml EX-101.PRE 240623
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 171169739
SIC: 2834 Pharmaceutical Preparations